A new portable device developed at the University of Chicago can detect gas molecules associated with diseases in airborne biomarkers.
The device, called Airborne Biomarker Localization Engine (ABLE), condenses dilute airborne biomarkers into concentrated liquid droplets for analysis.
ABLE can detect both non-volatile and volatile molecules in air in approximately 15 minutes.
Traditional methods like mass spectrometers are bulky and expensive, making them impractical for everyday environments.
The technology was inspired by the vulnerability of preterm infants in neonatal intensive care units.
The device could be used for early detection of conditions like inflammatory bowel disease and respiratory disorders.
Possible applications include mental health monitoring, infectious disease surveillance, and monitoring air quality.
ABLE aims to democratize biomarker sensing, moving diagnostics beyond the laboratory and into homes and clinics.
Researchers aim to further miniaturize and optimize the ABLE device to enhance sensitivity and energy efficiency.
Collaborations with health professionals are ongoing to test the device in real-world settings like NICUs and outpatient clinics.
The technology demonstrates unexpected evaporation physics in dilute droplets with multiple components.
Evidence suggests that the technology defies the limit set by Henry’s law, opening new possibilities for non-contact diagnostics and environmental monitoring.
The developers intend to expand applications to infectious disease surveillance and food spoilage detection.
The work has potential for widespread applications in non-contact diagnostics, environmental monitoring, and public health.
The research details are published in Nature Chemical Engineering.